わかもと製薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証STD医薬品4512/E00928-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2023/02/10日証協無担保0株0%0株0%2,700株+8%
2023/02/10日証協有担保564,815株+154.62%22,600株+143.01%357,900株+180.26%
2023/02/03日証協無担保0株0%0株0%2,500株-53.7%
2023/02/03日証協有担保221,826株-69.01%9,300株-90.27%127,701株-5.27%
2023/01/27日証協無担保0株0%0株0%5,400株+92.86%
2023/01/27日証協有担保715,878株-27.44%95,600株+2231.71%134,801株-26.1%
2023/01/20日証協無担保0株-100%0株0%2,800株+100%
2023/01/20日証協有担保986,632株+26.97%4,100株+156.25%182,400株+134.75%
2023/01/13日証協無担保500株-85.29%0株0%1,400株-48.15%
2023/01/13日証協有担保777,079株+22.44%1,600株-11.11%77,700株+87.68%
2023/01/06日証協無担保3,400株0%0株0%2,700株-64.01%
2023/01/06日証協有担保634,672株+67.85%1,800株-41.94%41,400株-43.83%
2022/12/30日証協無担保0株-100%0株0%7,502株+52.36%
2022/12/30日証協有担保378,125株-25.83%3,100株+72.22%73,700株-48.91%
2022/12/23日証協無担保2,400株0%0株0%4,924株+1131%
2022/12/23日証協有担保509,825株+6886.78%1,800株-10%144,264株+1235.78%
2022/12/16日証協無担保0株-100%0株0%400株-73.33%
2022/12/16日証協有担保7,297株-98.4%2,000株-59.26%10,800株-86.14%
2022/12/09日証協無担保3,400株+1033.33%0株0%1,500株-50%
2022/12/09日証協有担保455,375株+142.19%4,909株+718.17%77,900株+51.56%
2022/12/02日証協無担保300株-78.57%0株0%3,000株-80.52%
2022/12/02日証協有担保188,020株-21.95%600株0%51,400株-31.22%
2022/11/18日証協無担保200株-95.56%0株0%1,000株-86.67%
2022/11/18日証協有担保232,320株-73.48%24,200株-45.98%15,400株-89.42%
2022/11/11日証協無担保4,500株+4400%0株0%7,500株-18.48%
2022/11/11日証協有担保876,097株+1188.38%44,800株+39.13%145,520株+787.32%
2022/11/04日証協無担保100株-99.91%0株0%9,200株+53.33%
2022/11/04日証協有担保68,000株-95.3%32,200株+203.77%16,400株-78.28%
2022/10/28日証協無担保107,800株+2350%0株0%6,000株-46.9%
2022/10/28日証協有担保1,445,686株+21.43%10,600株+100%75,509株-48.1%
2022/10/21日証協無担保4,400株+91.3%0株0%11,300株+5.6%
2022/10/21日証協有担保1,190,538株-18.18%5,300株-29.33%145,500株+96.09%
2022/10/14日証協無担保2,300株0%0株0%10,701株-63.74%
2022/10/14日証協有担保1,454,991株+21.27%7,500株+15.38%74,200株-52.62%
2022/10/07日証協無担保0株-100%0株0%29,510株+227.63%
2022/10/07日証協有担保1,199,810株-16.24%6,500株-65.29%156,600株+74.38%
2022/09/30日証協無担保8,200株0%0株0%9,007株+45.25%
2022/09/30日証協有担保1,432,504株+431.88%18,727株+27.16%89,802株+46.86%

※株式分割は考慮していませんのでご注意ください。

Page Top